HighTower Advisors’s Teladoc Health TDOC Stock Holding History

HighTower Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-180	Closed	-$12.2K	–	3848
2023 Q3	$12.2K	Buy	+180	New	+$4.2K	﹤0.01%	3371
2021 Q4	–	Sell	-200	Closed	-$3K	–	3475
2021 Q3	$3K	Buy	200 +100	+100%	+$14.6K	﹤0.01%	3089
2021 Q2	$1K	Buy	100 +97	+3,233%	+$15.7K	﹤0.01%	3124
2021 Q1	$6K	Sell	3 -5	-63%	-$1.16K	﹤0.01%	2951
2020 Q4	$7K	Buy	+8	New	+$1.63K	﹤0.01%	2530
2020 Q3	–	Sell	-400	Closed	-$1K	–	2694
2020 Q2	$1K	Buy	+400	New	+$70.1K	﹤0.01%	2417

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

HighTower Advisors's TDOC Position: Q2 2026 in Review

HighTower Advisors increased its Teladoc Health (TDOC) stake by 21% in Q2 2026, buying an estimated $19.3K and bringing the position to 16,808 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

HighTower Advisors first reported a position in TDOC in Q2 2018 and has held it in 33 quarters since. The position peaked at $11.5M in Q4 2021. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

HighTower Advisors held 16,808 shares of Teladoc Health worth $143K as of Q2 2026.
HighTower Advisors bought 2,893 Teladoc Health shares in Q2 2026, an estimated $19.3K.
Teladoc Health made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3606 holding.
HighTower Advisors first reported a position in Teladoc Health in Q2 2018 and has held it in 33 quarters since.
HighTower Advisors's Teladoc Health position peaked at $11.5M in Q4 2021.
347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.